The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose escalation study of hPV19, a novel humanized monoclonal antibody against vascular endothelial growth factor (VEGF), in patients with advanced solid tumors refractory to standard therapy.
 
Dongmei Ji
No Relationships to Disclose
 
Weina Shen
No Relationships to Disclose
 
Hongzhen Li
Employment - Joinn Laboratories
 
Yan Xia
Employment - Joinn Laboratories
 
Yu Wang
Employment - Stainwei Biotech
 
Shiping Luo
Employment - Stainwei Biotech
 
Qunmin Zhou
Employment - Stainwei Biotech
Leadership - Stainwei Biotech
 
Yiqing Xu
Employment - Stainwei (I)
Leadership - Stainwei Biotech (I)
Stock and Other Ownership Interests - Stainwei Biotech
 
Junning Cao
No Relationships to Disclose